These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38084868)

  • 1. Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma.
    Chen Y; Chen Y; Liu W
    Cancer Biol Ther; 2024 Dec; 25(1):2287122. PubMed ID: 38084868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathway.
    Xia X; Zhao S; Chen W; Xu C; Zhao D
    Ir J Med Sci; 2023 Dec; 192(6):2653-2660. PubMed ID: 37017854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
    Li B; Lv Y; Zhang C; Xiang C
    J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
    He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXB2 increases the proliferation and invasiveness of colon cancer cells through the upregulation of CCT6A.
    Yang X; Tong Y; Ye W; Chen L
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35315492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes.
    Chen C; Luo L; Xu C; Yang X; Liu T; Luo J; Shi W; Yang L; Zheng Y; Yang J
    BMC Cancer; 2022 Jul; 22(1):790. PubMed ID: 35850748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCT6A knockdown suppresses osteosarcoma cell growth and Akt pathway activation in vitro.
    Zeng W; Wu M; Cheng Y; Liu L; Han Y; Xie Q; Li J; Wei L; Fang Y; Chen Y; Peng J; Shen A
    PLoS One; 2022; 17(12):e0279851. PubMed ID: 36584147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF677 inhibits oral squamous cell carcinoma growth and tumor stemness by regulating FOXO3a.
    Zhang Z; Zhang Y; Hu X; Chen Y; Zhuang L; Zhang S
    Hum Cell; 2023 Jul; 36(4):1464-1476. PubMed ID: 37129799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of circular RNA hsa_circ_0008898 on oral squamous cell carcinoma and its mechanism].
    Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):578-585. PubMed ID: 32842350
    [No Abstract]   [Full Text] [Related]  

  • 12. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
    Wang X; Zhang Y; Zhang S; Duan L
    Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
    Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
    BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
    Wang K; Jin J; Ma T; Zhai H
    Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
    Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
    J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircLPAR3 Acts as an Oncogene in Oral Squamous Cell Carcinoma Through Regulating the miR-643/HMGB2 Network.
    Fu Y; Qiu C; Yang Y; Lu J; Qi Y
    Biochem Genet; 2022 Jun; 60(3):882-898. PubMed ID: 34528144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
    Zhai J; Luo G
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
    Wang M; Feng Z; Li X; Sun S; Lu L
    Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
    Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
    Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.